{"id":"https://openalex.org/W7224318993","doi":"https://doi.org/10.1007/s12672-026-06171-x","title":"Nanotechnology strategies to enhance berberine efficacy in triple-negative breast cancer through delivery platforms and clinical translation challenges","display_name":"Nanotechnology strategies to enhance berberine efficacy in triple-negative breast cancer through delivery platforms and clinical translation challenges","publication_year":2026,"publication_date":"2026-10-29","ids":{"openalex":"https://openalex.org/W7224318993","doi":"https://doi.org/10.1007/s12672-026-06171-x"},"language":"en","primary_location":{"id":"doi:10.1007/s12672-026-06171-x","doi":"https://doi.org/10.1007/s12672-026-06171-x","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s12672-026-06171-x","pdf_url":null,"source":{"id":"https://openalex.org/S4210213696","display_name":"Discover Oncology","issn_l":"2730-6011","issn":["2730-6011"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-20","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Discover Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1007/s12672-026-06171-x","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5042487635","display_name":"Javed Ahamad","orcid":"https://orcid.org/0000-0002-9445-5879","observed_orcids":["https://orcid.org/0000-0002-9445-5879"]},"institutions":[{"id":"https://openalex.org/I908820301","display_name":"Tishk International University","ror":"https://ror.org/03pbhyy22","country_code":"IQ","type":"education","lineage":["https://openalex.org/I908820301"]}],"countries":["IQ"],"is_corresponding":false,"raw_author_name":"Javed Ahamad","raw_affiliation_strings":["Department of Pharmacognosy, Faculty of Pharmacy, Tishk International University, Erbil, Iraq"],"raw_orcid":"https://orcid.org/0000-0002-9445-5879","affiliations":[{"raw_affiliation_string":"Department of Pharmacognosy, Faculty of Pharmacy, Tishk International University, Erbil, Iraq","institution_ids":["https://openalex.org/I908820301"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5033027208","display_name":"Gudisa Bereda","orcid":"https://orcid.org/0000-0002-5982-9601","observed_orcids":["https://orcid.org/0000-0002-5982-9601"]},"institutions":[{"id":"https://openalex.org/I1290398368","display_name":"Marie Stopes International","ror":"https://ror.org/05mnyyy56","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I1290398368"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Gudisa Bereda","raw_affiliation_strings":["Department of Pharmacy, Marie Stopes International Ethiopia (MSIE), Ambo, Ethiopia"],"raw_orcid":"https://orcid.org/0000-0002-5982-9601","affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Marie Stopes International Ethiopia (MSIE), Ambo, Ethiopia","institution_ids":["https://openalex.org/I1290398368"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5033027208"],"corresponding_institution_ids":["https://openalex.org/I1290398368"],"apc_list":{"value":1690,"currency":"USD","value_usd":1690},"apc_paid":{"value":1690,"currency":"USD","value_usd":1690},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.83795411,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12059","display_name":"Berberine and alkaloids research","score":0.8925999999046326,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12059","display_name":"Berberine and alkaloids research","score":0.8925999999046326,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.07530000060796738,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.007300000172108412,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/berberine","display_name":"berberine","score":0.9369999766349792},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9990000128746033},{"id":"https://openalex.org/keywords/nanocarriers","display_name":"nanocarriers","score":0.7630000114440918},{"id":"https://openalex.org/keywords/drug-delivery","display_name":"drug delivery","score":0.7699999809265137},{"id":"https://openalex.org/keywords/polymeric-nanoparticles","display_name":"polymeric nanoparticles","score":0.847000002861023},{"id":"https://openalex.org/keywords/lipid-nanocarriers","display_name":"lipid-based nanocarriers","score":0.9890000224113464},{"id":"https://openalex.org/keywords/micelles","display_name":"micelles","score":0.7139999866485596},{"id":"https://openalex.org/keywords/dendrimers","display_name":"dendrimers","score":0.9350000023841858},{"id":"https://openalex.org/keywords/stimuli-responsive-nanomaterials","display_name":"stimuli-responsive nanomaterials","score":0.871999979019165},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.6520000100135803},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.796999990940094},{"id":"https://openalex.org/keywords/signaling-pathways","display_name":"signaling pathways","score":0.5960000157356262},{"id":"https://openalex.org/keywords/clinical-translation","display_name":"clinical translation","score":0.8370000123977661},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.4959999918937683}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7278000116348267},{"id":"https://openalex.org/C2780116568","wikidata":"https://www.wikidata.org/wiki/Q176525","display_name":"Berberine","level":2,"score":0.6452999711036682},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6044999957084656},{"id":"https://openalex.org/C18150654","wikidata":"https://www.wikidata.org/wiki/Q17153796","display_name":"Nanocarriers","level":3,"score":0.5544999837875366},{"id":"https://openalex.org/C128544194","wikidata":"https://www.wikidata.org/wiki/Q474859","display_name":"Translational research","level":2,"score":0.5430999994277954},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.44350001215934753},{"id":"https://openalex.org/C3020000205","wikidata":"https://www.wikidata.org/wiki/Q2412849","display_name":"Narrative review","level":2,"score":0.42480000853538513},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.40779998898506165},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.37450000643730164},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3619000017642975},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.33149999380111694},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.3127000033855438},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3125},{"id":"https://openalex.org/C149364088","wikidata":"https://www.wikidata.org/wiki/Q185917","display_name":"Translation (biology)","level":4,"score":0.3118000030517578},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.3093999922275543},{"id":"https://openalex.org/C2986637895","wikidata":"https://www.wikidata.org/wiki/Q953865","display_name":"Breast tumor","level":4,"score":0.3068000078201294},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.298799991607666},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.29499998688697815},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.28209999203681946},{"id":"https://openalex.org/C126511603","wikidata":"https://www.wikidata.org/wiki/Q1261145","display_name":"Targeted drug delivery","level":3,"score":0.2671000063419342},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.2639000117778778},{"id":"https://openalex.org/C2992053201","wikidata":"https://www.wikidata.org/wiki/Q2585693","display_name":"Clinical efficacy","level":2,"score":0.2567000091075897},{"id":"https://openalex.org/C61238886","wikidata":"https://www.wikidata.org/wiki/Q5121689","display_name":"Circulating tumor cell","level":4,"score":0.2558000087738037},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.25110000371932983}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1007/s12672-026-06171-x","doi":"https://doi.org/10.1007/s12672-026-06171-x","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s12672-026-06171-x","pdf_url":null,"source":{"id":"https://openalex.org/S4210213696","display_name":"Discover Oncology","issn_l":"2730-6011","issn":["2730-6011"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-20","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Discover Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1007/s12672-026-06171-x","doi":"https://doi.org/10.1007/s12672-026-06171-x","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s12672-026-06171-x","pdf_url":null,"source":{"id":"https://openalex.org/S4210213696","display_name":"Discover Oncology","issn_l":"2730-6011","issn":["2730-6011"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-20","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Discover Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7155084301","https://openalex.org/W7220929232","https://openalex.org/W4407721989","https://openalex.org/W4315647946","https://openalex.org/W7163913844","https://openalex.org/W7149688193","https://openalex.org/W7223033147","https://openalex.org/W4396551989","https://openalex.org/W4401836309","https://openalex.org/W7213918341"],"abstract_inverted_index":{"Triple-negative":[0],"breast":[1,8],"cancer":[2,9],"(TNBC)":[3],"is":[4],"the":[5,90,93,167],"most":[6],"aggressive":[7],"subtype.":[10],"It":[11],"remains":[12,182],"difficult":[13],"to":[14,24,81],"treat":[15],"because":[16,171],"of":[17,57,73,95,172,196],"its":[18,49],"heterogeneity,":[19],"metastatic":[20],"potential,":[21],"and":[22,33,43,64,75,109,133,145,154,163,177,194,219],"resistance":[23],"therapy.":[25],"Berberine":[26],"exhibits":[27],"promising":[28,202],"anticancer":[29],"activity.":[30],"However,":[31,179],"pharmacokinetic":[32],"delivery":[34,60],"limitations,":[35],"including":[36,125,136],"poor":[37],"solubility,":[38,149],"low":[39],"bioavailability,":[40,150],"rapid":[41],"metabolism,":[42],"inadequate":[44],"tumor":[45,152],"targeting,":[46],"may":[47],"limit":[48],"clinical":[50,180,221],"translation.":[51],"To":[52],"critically":[53,110],"review":[54,88,113],"molecular":[55],"mechanisms":[56],"berberine":[58,116],"nano-based":[59],"strategies,":[61],"translational":[62,169],"challenges,":[63],"future":[65],"perspectives":[66],"for":[67,92,204],"TNBC":[68,118,205],"treatment.":[69,206],"PubMed,":[70],"Scopus,":[71],"Web":[72],"Science,":[74],"Google":[76],"Scholar":[77],"searches":[78],"were":[79,106],"performed":[80],"identify":[82],"relevant":[83],"published":[84],"studies.":[85],"This":[86,112],"narrative":[87],"followed":[89],"Scale":[91],"Assessment":[94],"Narrative":[96],"Review":[97],"Articles":[98],"(SANRA)":[99],"framework.":[100],"The":[101],"findings":[102],"from":[103],"preclinical":[104],"studies":[105],"qualitatively":[107],"synthesized":[108],"appraised.":[111],"showed":[114],"that":[115],"suppresses":[117],"progression":[119],"by":[120,184],"modulating":[121],"multiple":[122],"signaling":[123],"pathways,":[124],"PI3K/AKT/mTOR,":[126],"EGFR/MEK/ERK,":[127],"NF-\u03baB,":[128],"STAT3,":[129],"AMPK,":[130],"TGF-\u03b2,":[131],"Wnt/\u03b2-catenin,":[132],"NLRP3.":[134],"Nanoformulations,":[135],"polymeric":[137],"nanoparticles,":[138],"lipid-based":[139,164],"nanocarriers,":[140],"dendrimers,":[141],"micelles,":[142],"inorganic,":[143],"hybrid,":[144],"stimuli-responsive":[146],"systems,":[147],"improved":[148],"stability,":[151],"accumulation,":[153],"intracellular":[155],"delivery.":[156],"These":[157],"improvements":[158],"enhanced":[159],"therapeutic":[160],"efficacy.":[161],"Polymeric":[162],"nanocarriers":[165],"demonstrated":[166],"greatest":[168],"potential":[170],"their":[173],"favorable":[174],"efficacy,":[175],"biocompatibility,":[176],"scalability.":[178],"translation":[181,208],"limited":[183],"insufficient":[185],"human":[186],"evidence,":[187],"safety":[188,213],"concerns,":[189],"manufacturing":[190],"complexity,":[191],"regulatory":[192,217],"uncertainty,":[193],"lack":[195],"standardized":[197,211],"formulations.":[198],"Nano-berberine":[199],"represents":[200],"a":[201],"strategy":[203],"Clinical":[207],"will":[209],"require":[210],"formulations,":[212],"assessments,":[214],"scalable":[215],"production,":[216],"alignment,":[218],"well-designed":[220],"trials.":[222]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-10-30T00:00:00"}